期刊
FASEB JOURNAL
卷 29, 期 3, 页码 1113-1123出版社
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.14-263822
关键词
p53; chronic HBV infection; PTBP1; FASTK
资金
- State Key Project Specialized for Infectious Diseases [2012ZX10002002-004-006, 2013ZX10002006-002-002]
- Key Program of Scientific Research [09ZD004]
- Program for Innovative Research Team in Science and Technology from Fujian Medical University [FMU-RT001]
Hepatitis B virus core protein (HBc) has been implicated in hepatocarcinogenesis through several mechanisms. Resistance of hepatitis B virus (HBV)-infected hepatocytes to apoptosis is considered one of the major contributors to the progression of chronic hepatitis to cirrhosis and ultimately to hepatocellular carcinoma. The Fas receptor/ligand (Fas/FasL) system plays a prominent role in hepatocyte death during HBV infection. Here we report that HBc mediates resistance of hepatoma cells to agonistic anti-Fas antibody (CH11)-induced apoptosis. WhenHBc was introduced into human hepatoma cells, the cells became resistant to CH11 cytotoxicity in a p53-dependent manner. HBc significantly down-regulated the expression of p53, total Fas, and membrane-bound Fas at them RNA and protein levels and reduced FasL mRNA expression. In contrast, HBc upregulated the expression of soluble forms of Fas by increasing Fas alternative mRNA splicing. Mechanistically, HBc-mediated Fas alternative mRNA splicing was associated with up-regulation of polypyrimidine tract-binding protein 1 and down-regulation of Fas-activated serine/threonine kinase. These results indicated that HBc may preventhepatocytes from Fas-induced apoptosis by the dual effects of reducing the expression of the proapoptotic form of Fas and enhancing the expression of the antiapoptotic form of the receptor, which may contribute to the survival and persistence of infected hepatocytes during chronic infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据